AECOM Share Price Target ‘$108.56’, now 21.2% Upside Potential

DirectorsTalk Interviews

AECOM with ticker code (ACM) have now 9 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $116.00 and $100.00 calculating the mean target share price we have $108.56. (at the time of writing). Given that the stocks previous close was at $89.57 and the analysts are correct then we can expect a percentage increase in value of 21.2%. Also worth taking note is the 50 day moving average now sits at $93.99 and the 200 day MA is $88.35. The total market capitalization for the company now stands at 12.27B. The stock price is currently at: $90.14 USD

The potential market cap would be $14,871,991,066 based on the market consensus.

The company has a dividend yield of 0.03%. Other points of data to note are a P/E ratio of 103.61, revenue per share of $111.89 and a 4.65% return on assets.

AECOM is a global provider of professional infrastructure consulting services for governments, businesses, and organizations across the world. The Company operates through three segments: Americas, International, and AECOM Capital (ACAP). The Americas segment provides planning, consulting, architectural and engineering design, and construction and program management services to commercial and government clients in the United States, Canada, and Latin America in end markets, such as transportation, water, government, facilities, environmental, and energy. The International segment offers planning, consulting, architectural and engineering design services and program management to commercial and government clients in Europe, the Middle East, Africa and the Asia-Pacific regions in end markets, such as transportation, water, government, facilities, environmental, and energy. The ACAP segment invests primarily in and develops real estate projects.

Share on:

Latest Company News

discoverIE delivers order growth and completes Keymat acquisition

For the quarter ended 31 December 2025, discoverIE recorded higher sales and orders, supported by robust margins and strong cash generation. T

Molten Ventures to host 2026 Investor Day on 11 February

Molten Ventures will host its annual Investor Day for institutional investors and analysts on Wednesday, 11 February 2026.

AstraZeneca Plc begins trading on the New York Stock Exchange

AstraZeneca has started trading its ordinary shares on the NYSE for the first time, aligning its listings across New York, London and Stockholm under a harmonised structure.

REACT Group to release Final Results on 5 February 2026

REACT Group plc, the specialist support services provider to the FM industry, confirms that its final results for the year ended 30 September 2025 will be released on Thursday, 5 February 2026.

Billington appoints Sharon Daly as Independent Non-Executive Director

Billington Holdings Plc has announced the appointment of Sharon Daly as an Independent Non-Executive Director and Chair of the Remuneration Committee, effective 2 February 2026.

XP Factory achieves record quarterly sales as Escape Hunt continues to outperform

XP Factory delivered record quarterly sales over the 2025/26 festive period, with UK owned and operated revenue rising 4.2% in the 13 weeks to 28 December 2025.

    Search

    Search